Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Michael King is an analyst at EF Hutton. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/03/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/01/2024 | APLM | Buy Now | Apollomics | $7.00 | -7.14% | Michael King44% | $1100 → $650 | Maintains | Buy | Get Alert |
| 08/23/2023 | APLM | Buy Now | Apollomics | $7.00 | 257.14% | Michael King44% | $2500 → $2500 | Assumes | Buy → Buy | Get Alert |
| 08/23/2023 | SONN | Buy Now | Sonnet BioTherapeutics | $1.24 | 440.32% | Michael King44% | → $1179.2 | Assumes | → Buy | Get Alert |
| 08/10/2023 | LTRN | Buy Now | Lantern Pharma | $3.25 | 238.46% | Michael King44% | → $11 | Reiterates | Buy → Buy | Get Alert |
| 06/26/2023 | LTRN | Buy Now | Lantern Pharma | $3.25 | 238.46% | Michael King44% | $11 → $11 | Maintains | Buy | Get Alert |
| 06/26/2023 | SONN | Buy Now | Sonnet BioTherapeutics | $1.24 | 440.32% | Michael King44% | → $1179.2 | Reiterates | Buy → Buy | Get Alert |
| 06/26/2023 | BMEA | Buy Now | Biomea Fusion | $2.10 | 1423.74% | Michael King44% | → $32 | Reiterates | Buy → Buy | Get Alert |
| 06/12/2023 | JSPR | Buy Now | Jasper Therapeutics | $4.09 | 67.46% | Michael King44% | → $68.5 | Reiterates | Buy → Buy | Get Alert |
| 05/25/2023 | APLM | Buy Now | Apollomics | $7.00 | 257.14% | Michael King44% | $2500 → $2500 | Assumes | Buy → Buy | Get Alert |
| 05/25/2023 | COEP | Buy Now | Coeptis Therapeutics | $9.25 | 8.11% | Michael King44% | → $200 | Assumes | → Buy | Get Alert |
| 05/25/2023 | LTRN | Buy Now | Lantern Pharma | $3.25 | 238.46% | Michael King44% | → $11 | Assumes | → Buy | Get Alert |
| 05/25/2023 | HOWL | Buy Now | Werewolf Therapeutics | $0.88 | 848.57% | Michael King44% | → $8.3 | Assumes | → Buy | Get Alert |
| 05/25/2023 | BMEA | Buy Now | Biomea Fusion | $2.10 | 1423.74% | Michael King44% | → $32 | Assumes | → Buy | Get Alert |
| 05/25/2023 | JSPR | Buy Now | Jasper Therapeutics | $4.09 | 67.46% | Michael King44% | → $68.5 | Assumes | → Buy | Get Alert |
| 05/25/2023 | SONN | Buy Now | Sonnet BioTherapeutics | $1.24 | 440.32% | Michael King44% | → $1179.2 | Assumes | → Buy | Get Alert |
| 05/18/2023 | LTRN | Buy Now | Lantern Pharma | $3.25 | — | Michael King44% | — | Initiates | → Neutral | Get Alert |
| 05/18/2023 | COEP | Buy Now | Coeptis Therapeutics | $9.25 | -35.14% | Michael King44% | → $120 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2023 | JSPR | Buy Now | Jasper Therapeutics | $4.09 | 67.46% | Michael King44% | → $68.5 | Reiterates | Buy → Buy | Get Alert |
| 05/10/2023 | COEP | Buy Now | Coeptis Therapeutics | $9.25 | -35.14% | Michael King44% | → $120 | Reiterates | → Buy | Get Alert |
| 05/04/2023 | BMEA | Buy Now | Biomea Fusion | $2.10 | 1423.74% | Michael King44% | $33 → $32 | Reiterates | → Buy | Get Alert |
| 05/01/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $602.33 | 43.11% | Michael King44% | → $862 | Reiterates | → Buy | Get Alert |
| 04/28/2023 | EXEL | Buy Now | Exelixis | $35.64 | -32.66% | Michael King44% | → $24 | Reiterates | → Buy | Get Alert |
| 04/27/2023 | OCEA | Buy Now | Ocean Biomedical | $0.05 | 32219.39% | Michael King44% | $10 → $17 | Maintains | Buy | Get Alert |
| 04/25/2023 | APLM | Buy Now | Apollomics | $7.00 | 257.14% | Michael King44% | → $2500 | Initiates | → Buy | Get Alert |
| 04/19/2023 | SONN | Buy Now | Sonnet BioTherapeutics | $1.24 | 440.32% | Michael King44% | → $1179.2 | Reiterates | → Buy | Get Alert |
| 04/13/2023 | OCEA | Buy Now | Ocean Biomedical | $0.05 | 18911.41% | Michael King44% | → $10 | Reiterates | → Buy | Get Alert |
| 04/06/2023 | BMEA | Buy Now | Biomea Fusion | $2.10 | 1471.35% | Michael King44% | → $33 | Reiterates | → Buy | Get Alert |
| 04/05/2023 | COEP | Buy Now | Coeptis Therapeutics | $9.25 | -35.14% | Michael King44% | → $120 | Reiterates | → Buy | Get Alert |
| 03/29/2023 | COEP | Buy Now | Coeptis Therapeutics | $9.25 | -35.14% | Michael King44% | → $120 | Reiterates | → Buy | Get Alert |
| 03/28/2023 | BMEA | Buy Now | Biomea Fusion | $2.10 | 1471.35% | Michael King44% | $22 → $33 | Maintains | Buy | Get Alert |
| 03/28/2023 | AGEN | Buy Now | Agenus | $1.59 | 421.98% | Michael King44% | → $166 | Reiterates | → Buy | Get Alert |
| 03/24/2023 | HOWL | Buy Now | Werewolf Therapeutics | $0.88 | 848.57% | Michael King44% | → $8.3 | Reiterates | → Buy | Get Alert |
| 03/24/2023 | BMEA | Buy Now | Biomea Fusion | $2.10 | 947.57% | Michael King44% | → $22 | Reiterates | → Buy | Get Alert |
| 03/23/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $602.33 | 43.11% | Michael King44% | $853 → $862 | Maintains | Buy | Get Alert |
| 03/22/2023 | BMEA | Buy Now | Biomea Fusion | $2.10 | 947.57% | Michael King44% | → $22 | Reiterates | → Buy | Get Alert |
| 03/21/2023 | LTRN | Buy Now | Lantern Pharma | $3.25 | 238.46% | Michael King44% | → $11 | Reiterates | → Buy | Get Alert |
| 03/21/2023 | BMEA | Buy Now | Biomea Fusion | $2.10 | 947.57% | Michael King44% | → $22 | Reiterates | → Buy | Get Alert |
| 03/20/2023 | EXEL | Buy Now | Exelixis | $35.64 | -32.66% | Michael King44% | → $24 | Reiterates | → Buy | Get Alert |
| 03/15/2023 | AGEN | Buy Now | Agenus | $1.59 | 421.98% | Michael King44% | → $166 | Reiterates | → Buy | Get Alert |
| 03/13/2023 | OCEA | Buy Now | Ocean Biomedical | $0.05 | 18911.41% | Michael King44% | → $10 | Initiates | → Buy | Get Alert |
| 03/09/2023 | JSPR | Buy Now | Jasper Therapeutics | $4.09 | 67.46% | Michael King44% | → $68.5 | Reiterates | → Buy | Get Alert |
| 03/03/2023 | EXEL | Buy Now | Exelixis | $35.64 | -32.66% | Michael King44% | → $24 | Reiterates | → Buy | Get Alert |
| 02/27/2023 | JSPR | Buy Now | Jasper Therapeutics | $4.09 | 67.46% | Michael King44% | → $68.5 | Reiterates | → Buy | Get Alert |
| 02/27/2023 | HOWL | Buy Now | Werewolf Therapeutics | $0.88 | 848.57% | Michael King44% | → $8.3 | Reiterates | → Buy | Get Alert |
| 02/24/2023 | XNCR | Buy Now | Xencor | $9.82 | 327.7% | Michael King44% | → $42 | Reiterates | → Buy | Get Alert |
| 02/24/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $266.83 | 13.93% | Michael King44% | → $304 | Reiterates | → Buy | Get Alert |
| 02/24/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $602.33 | 41.62% | Michael King44% | → $853 | Reiterates | → Buy | Get Alert |
| 02/24/2023 | NTLA | Buy Now | Intellia Therapeutics | $6.68 | 1636.5% | Michael King44% | $123 → $116 | Maintains | Buy | Get Alert |
| 02/21/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $266.83 | 13.93% | Michael King44% | → $304 | Initiates | → Buy | Get Alert |
| 02/21/2023 | JSPR | Buy Now | Jasper Therapeutics | $4.09 | 67.46% | Michael King44% | → $68.5 | Reiterates | → Buy | Get Alert |
| 02/17/2023 | HOWL | Buy Now | Werewolf Therapeutics | $0.88 | 848.57% | Michael King44% | → $8.3 | Reiterates | → Buy | Get Alert |
| 02/17/2023 | JSPR | Buy Now | Jasper Therapeutics | $4.09 | 67.46% | Michael King44% | → $68.5 | Reiterates | → Buy | Get Alert |
| 02/16/2023 | JSPR | Buy Now | Jasper Therapeutics | $4.09 | 67.46% | Michael King44% | $40 → $68.5 | Maintains | Buy | Get Alert |
| 02/15/2023 | LTRN | Buy Now | Lantern Pharma | $3.25 | 238.46% | Michael King44% | → $11 | Maintains | Buy | Get Alert |
| 02/15/2023 | SONN | Buy Now | Sonnet BioTherapeutics | $1.24 | 440.32% | Michael King44% | → $1179.2 | Reiterates | → Buy | Get Alert |
| 02/14/2023 | EXEL | Buy Now | Exelixis | $35.64 | -32.66% | Michael King44% | → $24 | Maintains | Buy | Get Alert |
| 02/08/2023 | EXEL | Buy Now | Exelixis | $35.64 | -32.66% | Michael King44% | → $24 | Reiterates | → Buy | Get Alert |
| 02/08/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $602.33 | 41.62% | Michael King44% | $851 → $853 | Maintains | Buy | Get Alert |
| 01/31/2023 | XNCR | Buy Now | Xencor | $9.82 | 327.7% | Michael King44% | → $42 | Initiates | → Buy | Get Alert |
| 01/30/2023 | XNCR | Buy Now | Xencor | $9.82 | 327.7% | Michael King44% | → $42 | Initiates | → Buy | Get Alert |
| 01/11/2023 | JSPR | Buy Now | Jasper Therapeutics | $4.09 | -2.21% | Michael King44% | → $40 | Maintains | Buy | Get Alert |
| 01/11/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $602.33 | 41.28% | Michael King44% | → $851 | Maintains | Buy | Get Alert |
| 01/11/2023 | EXEL | Buy Now | Exelixis | $35.64 | -32.66% | Michael King44% | $28 → $24 | Maintains | Buy | Get Alert |
| 12/22/2022 | AGEN | Buy Now | Agenus | $1.59 | 421.98% | Michael King44% | → $166 | Initiates | → Buy | Get Alert |
| 12/19/2022 | SONN | Buy Now | Sonnet BioTherapeutics | $1.24 | 440.32% | Michael King44% | → $1179.2 | Initiates | → Buy | Get Alert |
| 12/16/2022 | CMPX | Buy Now | Compass Therapeutics | $1.68 | 512.73% | Michael King44% | → $10.3 | Initiates | → Buy | Get Alert |
| 12/13/2022 | COEP | Buy Now | Coeptis Therapeutics | $9.25 | -35.14% | Michael King44% | → $120 | Initiates | → Buy | Get Alert |
| 12/12/2022 | COEP | Buy Now | Coeptis Therapeutics | $9.25 | -35.14% | Michael King44% | → $120 | Initiates | → Buy | Get Alert |
| 12/08/2022 | AGEN | Buy Now | Agenus | $1.59 | 421.98% | Michael King44% | → $166 | Initiates | → Buy | Get Alert |
| 12/05/2022 | HOWL | Buy Now | Werewolf Therapeutics | $0.88 | 848.57% | Michael King44% | → $8.3 | Initiates | → Buy | Get Alert |
| 11/08/2022 | BMEA | Buy Now | Biomea Fusion | $2.10 | 947.57% | Michael King44% | $27 → $22 | Maintains | Buy | Get Alert |
| 11/04/2022 | NTLA | Buy Now | Intellia Therapeutics | $6.68 | 1741.29% | Michael King44% | $130 → $123 | Maintains | Buy | Get Alert |
| 11/01/2022 | BMEA | Buy Now | Biomea Fusion | $2.10 | 1185.65% | Michael King44% | → $27 | Initiates | → Buy | Get Alert |
| 11/01/2022 | LTRN | Buy Now | Lantern Pharma | $3.25 | 238.46% | Michael King44% | → $11 | Initiates | → Buy | Get Alert |
| 11/01/2022 | EXEL | Buy Now | Exelixis | $35.64 | -21.44% | Michael King44% | → $28 | Initiates | → Buy | Get Alert |
| 11/01/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $602.33 | 41.28% | Michael King44% | → $851 | Initiates | → Buy | Get Alert |
| 11/01/2022 | NTLA | Buy Now | Intellia Therapeutics | $6.68 | 1846.08% | Michael King44% | → $130 | Initiates | → Buy | Get Alert |
| 11/01/2022 | JSPR | Buy Now | Jasper Therapeutics | $4.09 | -2.21% | Michael King44% | → $40 | Initiates | → Buy | Get Alert |
| 03/30/2022 | VINC | Buy Now | Vincerx Pharma | $0.62 | 4416.13% | Michael King44% | $500 → $560 | Maintains | Buy | Get Alert |
| 03/23/2022 | SRRK | Buy Now | Scholar Rock Holding | $31.50 | -23.81% | Michael King44% | → $24 | Initiates | → Buy | Get Alert |
| 03/11/2022 | SLRX | Buy Now | Salarius Pharmaceuticals | $0.66 | 504.69% | Michael King44% | $1000 → $800 | Maintains | Buy | Get Alert |
| 03/11/2022 | LTRN | Buy Now | Lantern Pharma | $3.25 | 1007.69% | Michael King44% | $34 → $36 | Maintains | Buy | Get Alert |
| 03/08/2022 | ANAB | Buy Now | AnaptysBio | $18.97 | 142.49% | Michael King44% | $43 → $46 | Maintains | Buy | Get Alert |
| 03/03/2022 | AGIO | Buy Now | Agios Pharmaceuticals | $28.44 | 237.55% | Michael King44% | $98 → $96 | Maintains | Buy | Get Alert |
| 03/02/2022 | AGEN | Buy Now | Agenus | $1.59 | 780.45% | Michael King44% | $240 → $280 | Maintains | Buy | Get Alert |
| 02/24/2022 | AGIO | Buy Now | Agios Pharmaceuticals | $28.44 | 237.55% | Michael King44% | $98 → $96 | Maintains | Buy | Get Alert |
| 02/24/2022 | XNCR | Buy Now | Xencor | $9.82 | 460.08% | Michael King44% | $61 → $55 | Maintains | Buy | Get Alert |
| 02/18/2022 | EXEL | Buy Now | Exelixis | $35.64 | 17.85% | Michael King44% | $52 → $42 | Maintains | Buy | Get Alert |
| 02/18/2022 | AGIO | Buy Now | Agios Pharmaceuticals | $28.44 | 244.59% | Michael King44% | $95 → $98 | Maintains | Buy | Get Alert |
| 01/20/2022 | KTRA | Buy Now | Kintara Therapeutics | — | — | Michael King44% | $10500 → $5250 | Maintains | Buy | Get Alert |
| 01/14/2022 | VINC | Buy Now | Vincerx Pharma | $0.62 | 3932.26% | Michael King44% | → $500 | Initiates | → Buy | Get Alert |
| 01/12/2022 | BMEA | Buy Now | Biomea Fusion | $2.10 | 519.02% | Michael King44% | → $13 | Initiates | → Buy | Get Alert |
| 01/10/2022 | XLO | Buy Now | Xilio Therapeutics | $0.70 | 5023.83% | Michael King44% | → $36 | Initiates | → Buy | Get Alert |
| 12/23/2021 | ELEV | Buy Now | Elevation Oncology | $0.26 | 4515.38% | Michael King44% | → $12 | Initiates | → Buy | Get Alert |
| 12/16/2021 | SONN | Buy Now | Sonnet BioTherapeutics | $1.24 | 61.29% | Michael King44% | → $4928 | Initiates | → Buy | Get Alert |
| 12/16/2021 | AGEN | Buy Now | Agenus | $1.59 | 654.67% | Michael King44% | → $240 | Initiates | → Buy | Get Alert |
| 12/15/2021 | XNCR | Buy Now | Xencor | $9.82 | 521.18% | Michael King44% | → $61 | Initiates | → Buy | Get Alert |
| 11/05/2021 | COGT | Buy Now | Cogent Biosciences | $5.72 | 441.96% | Michael King44% | $25 → $31 | Maintains | Buy | Get Alert |
| 11/05/2021 | NTLA | Buy Now | Intellia Therapeutics | $6.68 | 2624.51% | Michael King44% | $171 → $182 | Maintains | Buy | Get Alert |
| 11/05/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $602.33 | 40.12% | Michael King44% | $842 → $844 | Maintains | Buy | Get Alert |
| 11/04/2021 | AGIO | Buy Now | Agios Pharmaceuticals | $28.44 | 234.04% | Michael King44% | $93 → $95 | Maintains | Buy | Get Alert |
| 11/03/2021 | EXEL | Buy Now | Exelixis | $35.64 | 45.9% | Michael King44% | $65 → $52 | Maintains | Buy | Get Alert |
| 11/02/2021 | LTRN | Buy Now | Lantern Pharma | $3.25 | 946.15% | Michael King44% | $32 → $34 | Maintains | Buy | Get Alert |
| 10/22/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $602.33 | 39.79% | Michael King44% | $831 → $842 | Maintains | Buy | Get Alert |
| 10/20/2021 | CMPX | Buy Now | Compass Therapeutics | $1.68 | 554.37% | Michael King44% | → $11 | Initiates | → Buy | Get Alert |
| 10/18/2021 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | Michael King44% | → $9 | Initiates | → Buy | Get Alert |
| 10/11/2021 | COGT | Buy Now | Cogent Biosciences | $5.72 | 337.06% | Michael King44% | → $25 | Initiates | → Buy | Get Alert |
| 10/07/2021 | LTRN | Buy Now | Lantern Pharma | $3.25 | 884.62% | Michael King44% | → $32 | Initiates | → Buy | Get Alert |
| 09/28/2021 | KTRA | Buy Now | Kintara Therapeutics | — | — | Michael King44% | → $10500 | Initiates | → Buy | Get Alert |
| 09/15/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $602.33 | 37.96% | Michael King44% | $787 → $831 | Maintains | Buy | Get Alert |
| 08/25/2021 | SLRX | Buy Now | Salarius Pharmaceuticals | $0.66 | 655.86% | Michael King44% | → $1000 | Initiates | → Buy | Get Alert |
| 08/02/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $602.33 | 23.02% | Michael King44% | $729 → $741 | Maintains | Buy | Get Alert |
| 07/30/2021 | AGIO | Buy Now | Agios Pharmaceuticals | $28.44 | 227% | Michael King44% | $88 → $93 | Maintains | Buy | Get Alert |
| 06/29/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $602.33 | 16.71% | Michael King44% | → $703 | Initiates | → Buy | Get Alert |
| 06/28/2021 | NTLA | Buy Now | Intellia Therapeutics | $6.68 | 2459.84% | Michael King44% | $111 → $171 | Maintains | Buy | Get Alert |
| 06/22/2021 | ANAB | Buy Now | AnaptysBio | $18.97 | 126.67% | Michael King44% | → $43 | Initiates | → Buy | Get Alert |
| 06/15/2021 | EXEL | Buy Now | Exelixis | $35.64 | 31.87% | Michael King44% | → $47 | Initiates | → Buy | Get Alert |
| 06/11/2021 | NTLA | Buy Now | Intellia Therapeutics | $6.68 | 1561.65% | Michael King44% | → $111 | Initiates | → Buy | Get Alert |
| 06/10/2021 | AGIO | Buy Now | Agios Pharmaceuticals | $28.44 | 209.42% | Michael King44% | → $88 | Initiates | → Buy | Get Alert |
| 05/25/2021 | HOWL | Buy Now | Werewolf Therapeutics | $0.88 | 3557.14% | Michael King44% | → $32 | Initiates | → Buy | Get Alert |
| 10/18/2019 | SYRS | Buy Now | Syros Pharmaceuticals | $0.03 | 46142.77% | Michael King44% | $180 → $160 | Maintains | Market Outperform | Get Alert |
| 12/20/2018 | ANAB | Buy Now | AnaptysBio | $18.97 | 564.21% | Michael King44% | → $126 | Initiates | → Buy | Get Alert |
| 06/13/2018 | IDRA | Buy Now | Idera Pharmaceuticals | — | — | Michael King44% | $1088 → $544 | Maintains | Market Outperform | Get Alert |
| 11/13/2017 | ARGX | Buy Now | argenx | $583.62 | -93.83% | Michael King44% | $33 → $36 | Maintains | Market Outperform | Get Alert |
| 10/23/2017 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Michael King44% | → $38 | Initiates | → Market Outperform | Get Alert |
| 09/28/2017 | SYRS | Buy Now | Syros Pharmaceuticals | $0.03 | — | Michael King44% | — | Upgrade | Market Perform → Market Outperform | Get Alert |
| 08/29/2017 | LOXO | Buy Now | Loxo Oncology | — | — | Michael King44% | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 08/10/2017 | SYRS | Buy Now | Syros Pharmaceuticals | $0.03 | — | Michael King44% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 06/12/2017 | ARGX | Buy Now | argenx | $583.62 | -94.35% | Michael King44% | → $33 | Initiates | → Market Outperform | Get Alert |
| 03/22/2017 | IDRA | Buy Now | Idera Pharmaceuticals | — | — | Michael King44% | → $1088 | Initiates | → Market Outperform | Get Alert |
| 10/28/2016 | AGEN | Buy Now | Agenus | $1.59 | — | Michael King44% | — | Downgrade | Buy → Neutral | Get Alert |
| 07/25/2016 | SYRS | Buy Now | Syros Pharmaceuticals | $0.03 | — | Michael King44% | — | Initiates | → Outperform | Get Alert |
| 02/24/2014 | AGEN | Buy Now | Agenus | $1.59 | 403.11% | Michael King44% | → $160 | Initiates | → Buy | Get Alert |
